Abstract:Gliomas are the leading cause of death among adults with primary brain malignancies. Treatment for malignant gliomas remains limited, and targeted therapies have been incompletely explored. Nuclear factor erythroid 2-related factor 2 (Nrf2), a key transcription regulator for antioxidant and detoxification enzymes, is abundantly expressed in cancer cells. In this study, the role and mechanism of Nrf2 in cancer cell proliferation was investigated in multiple glioma cell lines. We first evaluated the expression patterns of Nrf2 in four glioma cell lines and found all four cell lines expressed Nrf2, but the highest level was observed in U251 cells. We further evaluated the biological functions of Nrf2 in U251 glioma cell proliferation by specific inhibition of Nrf2 using short hairpin RNA (shRNA). We found that Nrf2 depletion inhibited glioma cell proliferation. Nrf2 depletion also decreased colony formation in U251 cells stably expressing Nrf2 shRNA compared to scrambled control shRNA. Moreover, suppression of Nrf2 expression could lead to ATP depletion (with concomitant rise in AMP/ATP ratio) and consequently to AMPK-activated mTOR inhibition. Finally, activation of adenosine monophosphate-activated protein kinase (AMPK) by treated with phenformin, an AMPK agonist, can mimic the inhibitory effect of Nrf2 knockdown in U251 cells. In conclusion, our findings will shed light to the role and mechanism of Nrf2 in regulating glioma proliferation via ATP-depletion-induced AMPK activation and consequent mTOR inhibition, a novel insight into our understanding the role and mechanism of Nrf2 in glioma pathoetiology. To our knowledge, this is also the first report to provide a rationale for the implication of cross-linking between Nrf2 and mTOR signaling. (C) 2015 Elsevier Inc. All rights reserved.

The role of nuclear factor erythroid 2-related factor in cell proliferation of human glioma cell U251

Knockdown of NF-E2-related Factor 2 Inhibits the Proliferation and Growth of U251MG Human Glioma Cells in a Mouse Xenograft Model

Influence of Small Interfering RNA-mediated Inhibiting Human Runt-Related Transcription Factor 2 and Galectin-3 Gene on Proliferation and Apoptosis of Glioma Cell U251

GSH Depletion and Consequent AKT Inhibition Contribute to the Nrf2 Knockdown-Induced Decrease in Proliferation in Glioblastoma U251 Cells.

Function Study of Epha2 Gene in the Cell Apoptosis, Growth, Migration and Invasion of Glioma Cell Line U251

Differential Nrf2 expression between glioma stem cells and non-stem-like cells in glioblastoma.

ERK and PI3K Signaling Cascades Induce Nrf2 Activation and Regulate Cell Viability Partly Through Nrf2 in Human Glioblastoma Cells.

Correlation of Nrf2 and HIF-1α in Glioblastoma and Their Relationships to Clinicopathologic Features and Survival

Silencing Nrf2 Impairs Glioma Cell Proliferation Via AMPK-activated Mtor Inhibition.

Knockdown of Nrf2 Suppresses Glioblastoma Angiogenesis by Inhibiting Hypoxia-Induced Activation of HIF-1α.

Correction To: Nrf2 is Required to Maintain the Self-Renewal of Glioma Stem Cells

Ubiquitination of p21 by E3 ligase RNF135 promotes the proliferation of human glioblastoma cells

GDNF triggers proliferation of rat C6 glioma cells via the NF-κB/CXCL1 signaling pathway

Different Nrf2 Expressions in Glioblastoma Cell Lines and Glioma Stem Cells from Xenografts

NEK2 promotes TP53 ubiquitination to enhance the proliferation and migration of TP53 wild-type glioblastoma cells

Effect of down-regulation of Nrf2 by RNAi on autophagy in human glioma cell line U251

Knockdown of Nuclear Factor Erythroid 2-Related Factor 2 by Lentivirus Induces Differentiation of Glioma Stem-Like Cells.

Nuclear Respiratory Factor 1 (NRF1) Transcriptional Activity-Driven Gene Signature Association with Severity of Astrocytoma and Poor Prognosis of Glioblastoma

Up-Regulation of microRNA-183 Promotes Cell Proliferation and Invasion in Glioma By Directly Targeting NEFL

Inhibition of EGR1 Inhibits Glioma Proliferation by Targeting CCND1 Promoter

Knockdown of Nupr1 Inhibits the Proliferation of Glioblastoma Cells Via Erk1/2, P38 Mapk and Caspase-3